News & Events
![Are personalized DNA diets ready for prime time? [OPMN Newsletter #27]](https://oldsite.ontariogenomics.ca/wp-content/uploads/2015/09/OPMN_00.jpg)
Global study explores genetics of diabetes
August 8, 2016McGill researchers were amongst 300 + scientists across the globe collaborating to understand the genetic roots of Type 2 diabetes using genomic big data from more than 100,000 patients. With this study there are now over 80 genetic regions that contribute to Type 2 diabetes risk, along with diet and exercise.
New genetic findings on depression
August 8, 2016In what is by far the largest study of its kind focused on major depressive disorder, researchers from Pfizer, Massachusetts General Hospital and 23andMe identified genetic markers associated with depression among people of European ancestry.
Fighting food fraud with DNA barcoding
August 8, 2016For years, experts have been sounding the alarm on mislabelling and food fraud. Now, scientists at the University of Guelphs Centre for Biodiversity Genomics (CBG) are using DNA barcoding to determine whether your food is really what you think it is
DNA sequencer sent to space station
August 8, 2016NASA has sent a DNA sequencer to the International Space Station in an effort to help astronauts monitor their own health.
Soy research fights food poisoning
August 8, 2016University of Guelph researchers are using soy extracts to prevent the growth of microbial pathogens that cause food-borne illnesses.
Biosensor developed to identify allergens faster
July 20, 2016Canadian scientists have developed a nanotechnology and aptamer based biosensor to detect allergens such as peanut protein and gluten.
Researchers harness DNA in a super-efficient sensor
July 20, 2016Researchers at McMaster University have established a way to harness DNA as the engine of a microscopic “machine”.
The newest tool in the fight against cancer is a huge genetic database
July 20, 2016Two petabytes of genomic and clinical data were released. The trove features 440,000 DVDs worth of information—including full genome sequences—from 12,000 patients, raw and unprocessed. How will it help improve cancer treatment?